Study Details
A study of ASP2138 in adults with stomach cancer, gastroesophageal junction cancer, pancreatic cancer
Clinicaltrials.gov ID
Astellas Study ID
2138-CL-0101
EudraCT ID
N/A
Condition
Stomach or Esophageal Cancer, Pancreatic Cancer
Phase
Phase 1
Age
18 Years - N/A
Sex
Female & Male
Product
ASP2138
Type
Interventional
Trial Dates
Jun 2022 - Dec 2025
Masking
None (Open Label)
Enrollment number
240
A Phase 1/1b Study of ASP2138 in Participants with Metastatic or Locally Advanced Unresectable Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma or Metastatic Pancreatic Adenocarcinoma Whose Tumors Have Claudin (CLDN) 18.2 Expression
Study summary
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A study of ASP2138 in adults with stomach cancer, gastroesophageal junction cancer, pancreatic cancer? Contact us by filling our your information to the right and we’ll respond to you.
Locations
National Cancer Center Hospital East
Kashiwa, Japan
National Cancer Center Hospital
Chuo-ku, Japan
The Cancer Institute Hospital of Japanese Foundation for Cancer Research
Koto-ku, Japan
Aichi Cancer Center
Nagoya, Japan
Kanagawa Cancer Center
Yokohama, Japan
UCLA Dept of Medicine – Hematology/Oncology, Santa Monica
Santa Monica, United States, 90404
UT Southwestern Medical Center
Dallas, United States, 75390
Froedtert Hospital and the Medical College of Wisconsin
Milwaukee, United States, 53226
Virginia Mason Medical Center
Seattle, United States, 98101
Site KR82002
Jongno-gu, Republic of Korea
Site KR82004
Seongnam-si, Republic of Korea
Site KR82001
Guro-gu, Republic of Korea
Site KR82005
Seodaemun-gu, Republic of Korea
Memorial Sloan Kettering Cancer Center
New York, United States, 10065